As of 4:02pm ET
| -0.14 / -0.37%|
The 24 analysts offering 12-month price forecasts for GlaxoSmithKline have a median target of 46.12, with a high estimate of 52.24 and a low estimate of 35.10. The median estimate represents a +22.83% increase from the last price of 37.55.
The current consensus among 25 polled investment analysts is to Buy stock in GlaxoSmithKline. This rating has held steady since November, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.